Ticker HubNYSE

DNA

Ginkgo Bioworks Holdings, Inc.

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest price

$10.02+0.30%

As of Oct 26, 2026, 7:00 PM EDT · Market data by Massive

Market cap

$672.7M

Volume

1.3M

Previous close

$9.99

Day range

$9.69 – $10.11

Listed

Apr 19, 2021

Coverage

7 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$10.32$10.12$9.91$9.71$9.50Tue, 10/20Wed, 10/21Thu, 10/22Fri, 10/23Mon, 10/26
Five-day open $10.04Latest interval $10.02

Newsroom

Latest DNA coverage

Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
NewsFeb 24, 2023

Malaysian Genomics to Offer World's First DNA-Driven Fertility Test

[ad_1] PETALING JAYA, Malaysia – (NewMediaWire) – February 23, 2023 – (ACN Newswire) – Malaysian Genomics Resource Centre Bhd [MGRC], a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic collaboration agreement with Divine Genes Sdn Bhd to collaborate on business opportunities in r

DNAJAYAACNMGRC
SCD
NewsSep 23, 2020

Kashif Khan, CEO of the DNA Company and My Next Health, Proudly Announces the Appointments of J. Bernard Rice as Director and Alan Morell as Senior Advisor Media Marketing

[ad_1] Toronto – (NewMediaWire) – September 23, 2020 – Announced today, Kashif Khan, CEO and Founder of the DNA Company and My Next Health proudly announces the appointments of J. Bernard Rice as Director and Alan Morell as Senior Advisor Media Marketing. Said CEO Kashif Khan: "As we cross over from being a leader in functional genomics ...

DNA
J&J takes stake in Locus’ CRISPR-based ‘Pac-Man’ antimicrobials
BiotechJan 4, 2019

J&J takes stake in Locus’ CRISPR-based ‘Pac-Man’ antimicrobials

[ad_1] Just over a yr after its first-round financing, CRISPR firm Locus Biosciences has signed up Johnson & Johnson as its first massive pharma accomplice and pocketed a $20 million upfront payment. While most CRISPR firms are taking a look at making use of the CRISPR-Cas9 gene-editing know-how to human illnesses, Locus is taking a ...

FREEDAILYDNA
4 Facts About Using Genetics in Pursuit of a More Perfect Christmas Tree
BiotechDec 21, 2018

4 Facts About Using Genetics in Pursuit of a More Perfect Christmas Tree

[ad_1] What will your Christmas items be positioned beneath this yr? A Fraser fir? A Douglas fir? An synthetic tree? While some people love the look and odor of a actual Christmas tree, others desire the low maintenance and longevity of a man-made tree. But what if we might use genetics to enhance the Christmas ...

DNA
CRISPR controls obesity in mice by amplifying rather than editing genes
BiotechDec 13, 2018

CRISPR controls obesity in mice by amplifying rather than editing genes

[ad_1] The genes SIM1 and MC4R regulate food consumption by signaling the sensation of being full, which is why mutations in these genes are related to extreme obesity. Even if simply one of many two copies of these genes {that a} person inherits from each dad and mom is unhealthy, she or he will most ...

FREEDAILYUCSFDNA
SCD
BiotechDec 13, 2018

Nobel Prize-Winning Chemists: Misguided GMO Fears Could Hinder Technology’s Societal Benefits

[ad_1] On Friday, December 7, two winners of the 2018 Nobel prize for Chemistry – American chemical engineer Frances Arnold and British biochemist Sir Gregory Winter – expressed concern that misguided fears about genetically modified (GM) meals might hinder the various societal advantages the know-how gives and curtail necessary scientific developments. Acco

GMOGMDNANAS
SCD
PharmaMay 25, 2018

Malaria: Scientists urged to not underestimate CRISPR’s dangers

[ad_1] Similar to new Hollywood feature Rampage, a current examine has urged the life sciences business not to underestimate the dangers that would cover inside CRISPR Cas9. Although the movie has been criticised for wildly exaggerating the capabilities of the gene enhancing method, it may be recognised for its effort to draw focus from the ...

WHORNADNA
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.